Microdosing means starting with a much smaller dose of a medication and increasing gradually over time, instead of jumping straight to the higher doses that are often used later in treatment.
‍
For GLP-1/GIP medications, that can mean:

• Letting your body get used to the medicine slowly
  
• Reducing the likelihood of uncomfortable GI side effects at the start
  
• Giving your clinician room to personalize your dose as you progress.
  

Your GLP ONE clinician will review your health history, and goals to decide whether a microdosed plan is appropriate for you, and what dose you should start with.

Our microdose program is built for people who want the benefits of GLP-1 treatment with a more gentle on-ramp. Potential benefits of microdosed treatments, when clinically appropriate, may include:

• Improved tolerability at the start – Many people find that beginning with lower doses makes early nausea and GI symptoms easier to manage.
  
• Gradual, sustainable progress – Dosing can be increased thoughtfully over time based on how you’re feeling and responding.
  
• Personalized care – Your clinician has more flexibility to fine-tune your dose for your body, instead of locking into a one-size-fits-all schedule.
  
• Coordinated support – You’ll have access to our care team to discuss side effects, questions, or dose adjustments as your program continues.
  

**Microdosing does not remove all risk of side effects and does not guarantee weight loss—but it’s one more way we try to make your experience safer, more comfortable, and easier to stick with over time.

What is a GLP-1 and GIP receptor agonist? These hormones help regulate appetite, blood sugar, and how your body responds to food.
‍
By starting with a lower, microdosed amount and increasing more gradually when medically appropriate, your clinician aims to allow your gut and nervous system more time to adapt